Page last updated: 2024-08-24

atorvastatin and cholest-5-ene-3,4-diol

atorvastatin has been researched along with cholest-5-ene-3,4-diol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YH; DeGorter, MK; Dresser, GK; Hegele, RA; Iwuchukwu, O; Kim, RB; Myers, K; Schwarz, UI; Suskin, N; Tirona, RG; Wei, WQ; Wilke, RA; Zou, G	1
Hukkanen, J; Hyötyläinen, T; Morin-Papunen, L; Orešič, M; Piltonen, T; Puurunen, J; Ruokonen, A; Savolainen, MJ; Tapanainen, JS	1
Björkhem-Bergman, L; Diczfalusy, U; Eriksson, M; Nylén, H; Parini, P	1

Trials

2 trial(s) available for atorvastatin and cholest-5-ene-3,4-diol

Article	Year
Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circulation. Cardiovascular genetics, 2013, Volume: 6, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alleles; Atorvastatin; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cholesterol; Cohort Studies; Cytochrome P-450 CYP3A; Databases, Factual; Female; Fluorobenzenes; Genotype; Heptanoic Acids; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Linear Models; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Neoplasm Proteins; Organic Anion Transporters; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides	2013
The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity. British journal of clinical pharmacology, 2015, Volume: 80, Issue:3 Topics: Adult; Atorvastatin; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Female; Humans; Hydroxycholesterols; Middle Aged; Polycystic Ovary Syndrome	2015

Article

Year

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.

Circulation. Cardiovascular genetics, 2013, Volume: 6, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Alleles; Atorvastatin; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cholesterol; Cohort Studies; Cytochrome P-450 CYP3A; Databases, Factual; Female; Fluorobenzenes; Genotype; Heptanoic Acids; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Linear Models; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Neoplasm Proteins; Organic Anion Transporters; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides

2013

The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.

British journal of clinical pharmacology, 2015, Volume: 80, Issue:3

Topics: Adult; Atorvastatin; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Female; Humans; Hydroxycholesterols; Middle Aged; Polycystic Ovary Syndrome

2015

Other Studies

1 other study(ies) available for atorvastatin and cholest-5-ene-3,4-diol

Article	Year
Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations. Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:6 Topics: Atorvastatin; Biomarkers; Cholesterol; Cytochrome P-450 CYP3A; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gallstones; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Sweden	2016

Article

Year

Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations.

Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:6

Topics: Atorvastatin; Biomarkers; Cholesterol; Cytochrome P-450 CYP3A; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gallstones; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Sweden

2016